|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Cash | ||||||||
| Due from related party | ||||||||
| Prepaid Expenses | ||||||||
| Total current assets | ||||||||
| Other assets | ||||||||
| Marketable securities held in Trust Account | ||||||||
| Total Assets | ||||||||
| Liabilities and Shareholders' Deficit | ||||||||
| Accrued offering costs and expenses | ||||||||
| Convertible Promissory Note – Related Party | ||||||||
| Due to related party | ||||||||
| Total current liabilities | ||||||||
| Deferred legal fees | ||||||||
| Deferred underwriting fee | ||||||||
| Warrant liabilities | ||||||||
| Total Liabilities | ||||||||
| Class A Ordinary shares subject to possible redemption, 27,128,532 shares at redemption value | ||||||||
| Shareholders' Deficit: | ||||||||
| Preferred shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding | ||||||||
| Common stock par value | ||||||||
| Common Class A | ||||||||
| Common Class B | ||||||||
| Additional paid-in capital | ||||||||
| Accumulated deficit | ||||||||
| Total Shareholders' Deficit | ||||||||
| Total Liabilities and Shareholders' Deficit |
Loading...
